Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

Abstract

Simulations showed that longer infusions increase plasma PTA but decrease CSF PTA. CSF penetration is worsened with long infusions so increasing dose frequency to achieve therapeutic targets should be considered.